NeRRe Therapeutics
PrivateLast Round
Series B
Extension
Jul 7, 2021
Total Funding Raised
$74.73M
Company Overview
NeRRe Therapeutics is a clinical-stage biotechnology company that develops a portfolio of neurokinin receptor antagonists to treat debilitating conditions caused by neuronal hypersensitivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeRRe Therapeutics Comparables
Compare NeRRe Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axalbion | 85% | |
| Nocion Therapeutics | 81% | |
| Melius Pharma | 79% | |
NeRRe Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 7, 2021 | ||||
| Series B | Jan 5, 2017 | ||||
| Series A | Dec 19, 2012 |
Key People
Founding team and executive leadership
NeRRe Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B Extension, Series B |
| Forbion | Series B Extension, Series B |
| Future Fund | Series B Extension |
| Advent Life Sciences | Series B Extension, Series B |
| Fountain Healthcare Partners | Series B Extension, Series B |
| OrbiMed | Series B Extension, Series B |
| Advent Venture Partners | Series A |
NeRRe Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeRRe Therapeutics's valuation, stock price, and market status.